www.europeanceo.com/awards-2018/best-ceos/37
The European CEO Awards 2018 recognise the leaders who have an eye for innovation and, having firmly positioned their companies at the front of the pack, are now shaping the industries they work in.
Justification for this award includes the words:
"Mitidieri has shown a commitment to maintaining the firm's leading position within the global pharmaceuticals and pain management industry".
One of Mitidieri's main ambitions has been to implement an organisational model based on responsibility and meritocracy, rather than rigid internal hierarchies. Such an ideal falls in line with Sintetica's aim to create a working environment based on innovative ideas and positive dynamics, resulting in first-rate products that help hundreds of thousands of patients worldwide.
Most recently, Sintetica obtained marketing authorisation in the USA for its product Clorotekal, making it one of very few SMEs in the world to have registered an original pharmaceutical product in the country.
You can find an extended article from page 56 in the virtual edition of the issue here: https://www.europeanceo.com/magazine/


* European CEO is a leading subscription-based print and online publication, delivered quarterly to c-suite executives in 28 countries throughout Europe. With a network of journalists reporting to headquarters in London, European CEO provides the numbers, detailed analysis, strategy and guidance needed to make qualified business decisions in Europe's diverse marketplace.

The 2018 Brand of the Year Awards recognize and reward organizations that have performed exceptionally over the previous 12 months, becoming dynamic forces within their industries. The judging panel look not only for businesses of world class quality, but those that strive to push boundaries, challenge perceptions and respond to global problems; earning respect from their peers and becoming employers of choice. Sintetica SA impressed the panel with its clear commitment to ongoing development, innovation and "quality without compromise" - the company's mantra.

Sintetica SA's CEO Augusto Mitidieri is leading the way in a new business model that encourages collaborative and horizontal working, combining state of the art technology with a human-centred approach. The company has come a long way since it was formed almost 100 years ago, going from a small business in Switzerland to a global company employing 300 people across 29 countries. Delivering injectable anaesthetics and analgesics to patients worldwide, the company has been the market leader in its field for many years and is now forging the way in the growing field of neuromodulation. The global division was only established in 2012, but growth is already exceeding 200% - a testament to the hard work and commitment of the CEO and his team.

Mitidieri says that the company's culture of respect has played an important role in its success. "What differentiates us from competitors is that all strategic choices are based on values of respect, a core value that permeates across every employee. It is about creating a pleasant environment in which employees can work and express themselves. When hiring new employees, we look for 'smart' people who share our thirst for diversity, our respect for traditions and our aim to be a leading global company."

This "people first" approach extends way beyond the staff team, positively affecting relationships with business partners and realizing the best possible care solutions for patients. Mitidieri's innovative new organization model, the 'Human Centered Organization', is based on the idea of responsibility and meritocracy rather than hierarchy, with managers moving from a role of command to a coaching style.

This refreshing approach certainly appears to be working. The company has recently obtained the go-ahead to market a new drug application in the United States; an outstanding achievement as one of the few small-medium sized companies in the world to register a new product in the US. It is also developing a radical new innovation in the field of post-surgery pain relief that has the potential to change the way pain is managed throughout the world.

For being an international force of excellence in the pharmaceutical sector, with particular reference to the treatment of pain. Thanks to its CEO's charisma and highly professional team, Sintetica has proven itself to be one of the fastest growing realities in the market and perfectly satisfies the CSR criteria.
[Le Fonti Awards]

The motivation of this acknowledgement comes from the material representation of the spirit, envisioned by Augusto Mitidieri and embodied by the entire company, with which Sintetica manages its impressive expansion on the global market, strengthened by products of the highest quality and efficiency.

The award of CEO of the Year for Corporate Social Responsibility is further acknowledgement of the excellent work Sintetica does as a whole.

And Mitidieri is determined that Sintetica - whom he has worked with for the past 17years – will remain a leading player within the industry. The 95-year-old company develops injectable anaesthetics and analgesics on a global scale. These are specifically used for local anaesthesia, pain management and neuromodulation. Mitidieri regards development, production and marketing as crucial areas for the company's future strategy.

Receiving his Best CEO Award from the magazine's executives, Mitidieri insisted that innovation within his industry wasn't merely about products, but also management style and organisation.

"Getting this right has been one of the key elements of our success here at Sintetica"

he declared.

Sintetica has its HQ in Switzerland, where it employs around 40 per cent of the company's total workforce. Other countries in which it has a base includes Germany, Austria, Italy and the United Kingdom.
In order for sintetica to retain its global leadership peg Mitidieri believes strategic partnering and business development are the keys to long-term growth.
"Our specialist sales teams in Switzerland, Germany, Austria, the UK and Ireland directly promote and market our products, while our Global Division delivers our top medicines through a network of strategic international worldwide partners" ex-lained Mitidieri, who is a graduate in Management Engineering from the Politecnico di Milano.
He is hardly apologetic in admitting his 'pickiness' when it comes to choosing business partners. They must share the values of Sintetica, particularly its way of prioritising people and relationships over profit.

"All our partners must meet strict ethical criteria and share our innovation-driven quality without compromising our value proposition"

said Mitidieri.
As you would expect, Sintetica is a company which regards staff as a core resource. As such Mitidieri strives to offer a creative culture and doesn't even mind risk taking too much, provided it's what he would describe as "informed".
He added:

"Making Sintetica a great place to work is our belief and is, in fact, part of our DNA."

The statement regarding Mitidieri's award is

"For his capacity to lead with foresight and attention to human resources in the context of an international specialization in injectable products for pain relief and therapy. In particular, for having invested in the education vand continuous training of the employees in terms of the global standards for Corporate social responsibility and foreign development."

the sentence was translated from Italian by Sintetica

The "Le Fonti" Awards are incorporated in the IAIR system of international awards, an event of great prominence for the business community. It reunites corporate leaders, legal offices and individuals from the highest tiers of the financial world.

This new award refines the already impressive recent prizes bestowed upon Sintetica SA as Pharmaceutical Company of the year 2016 Switzerland and upon Augusto Mitidieri as European CEO of the year 2016.